PMID- 36100550 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231110 IS - 2531-1387 (Electronic) IS - 2531-1379 (Print) IS - 2531-1379 (Linking) VI - 45 IP - 4 DP - 2023 Oct-Dec TI - Natural killer cells 56(bright)16(-) have higher counts in the umbilical cord blood than in the adult peripheral blood. PG - 419-427 LID - S2531-1379(22)00110-9 [pii] LID - 10.1016/j.htct.2022.07.001 [doi] AB - INTRODUCTION AND HYPOTHESIS: Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cells for allogeneic hematopoietic stem cell transplantation in the absence of a compatible donor. The UCB transplantation has a lower incidence of chronic graft versus host disease (GvHD), but is associated with slower engraftment and slower immune reconstitution, compared to other sources. Dendritic cells (DCs) and Natural Killer cells (NKs) play a central role in the development of GvHD and the graft versus leukemia (GvL) effect, as well as in the control of infectious complications. METHOD: We quantified by multiparametric flow cytometry monocytes, lymphocytes, NK cells, and DCs, including their subsets, in UCB samples from 54 healthy newborns and peripheral blood (PB) from 25 healthy adult volunteers. RESULTS: In the UCB samples, there were higher counts of NK cells 56(bright)16(-) (median 0.024 x 109/L), compared to the PB samples (0.012 x 109/L, p < 0.0001), NK 56(dim)16(bright) (median 0.446 x 109/L vs. 0.259 x 109/L for PB samples, p = 0.001) and plasmacytoid dendritic cells (pDCs, median 0.008 x 109/L for UCB samples vs. 0.006 x 109/L for PB samples, p = 0.03). Moreover, non-classic monocyte counts were lower in UCB than in PB (median 0.024 x 109/L vs. 0.051 x 109/L, respectively, p < 0.0001). CONCLUSION: In conclusion, there were higher counts of NK cells and pDCs and lower counts of non-classic monocytes in UCB than in PB from healthy individuals. These findings might explain the lower incidence and severity of chronic GvHD, although maintaining the GvL effect, in UCB transplant recipients, compared to other stem cell sources. CI - Copyright (c) 2022 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espana, S.L.U. All rights reserved. FAU - de Molla, Vinicius Campos AU - de Molla VC AD - Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil; Hospital 9 de Julho, Sao Paulo, Brazil. FAU - Barbosa, Miriam Cristina Rodrigues AU - Barbosa MCR AD - Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil. FAU - Junior, Alfredo Mendrone AU - Junior AM AD - Hospital 9 de Julho, Sao Paulo, Brazil. FAU - Goncalves, Matheus Vescovi AU - Goncalves MV AD - Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil. FAU - Guirao, Eliza Kimuraa Fabio AU - Guirao EKF AD - Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil. FAU - Yamamoto, Mihoko AU - Yamamoto M AD - Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil. FAU - Arrais-Rodrigues, Celso AU - Arrais-Rodrigues C AD - Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil; Hospital 9 de Julho, Sao Paulo, Brazil. LA - eng PT - Journal Article DEP - 20220819 PL - Brazil TA - Hematol Transfus Cell Ther JT - Hematology, transfusion and cell therapy JID - 101725732 PMC - PMC10627873 OTO - NOTNLM OT - Natural killer cells OT - Peripheral blood OT - Plasmacytoid dendritic cell OT - Umbilical cord blood COIS- Conflicts of interest There are no conflicts of interest to report. EDAT- 2022/09/14 06:00 MHDA- 2022/09/14 06:01 PMCR- 2022/08/19 CRDT- 2022/09/13 22:06 PHST- 2022/01/31 00:00 [received] PHST- 2022/06/05 00:00 [revised] PHST- 2022/07/03 00:00 [accepted] PHST- 2022/09/14 06:01 [medline] PHST- 2022/09/14 06:00 [pubmed] PHST- 2022/09/13 22:06 [entrez] PHST- 2022/08/19 00:00 [pmc-release] AID - S2531-1379(22)00110-9 [pii] AID - 10.1016/j.htct.2022.07.001 [doi] PST - ppublish SO - Hematol Transfus Cell Ther. 2023 Oct-Dec;45(4):419-427. doi: 10.1016/j.htct.2022.07.001. Epub 2022 Aug 19.